Company intelligence / Profile preview

MOBILion Systems

Chadds Ford, Pennsylvania, United Statesmobilionsystems.com ↗

Ownership: Private
Employees: ~68
Development stage: Commercial

Overview

MOBILion Systems commercializes high-resolution ion mobility mass spectrometry instruments that enable faster, more accurate separation and identification of complex molecules. Their technology improves biopharmaceutical characterization, accelerates drug development processes, enhances biomarker discovery capabilities, and supports advanced diagnostics. The company’s HRIM-MS platform offers superior resolution and throughput compared to traditional approaches.

Therapeutic areas: Other
Modalities: Device (analytical instrument)Diagnostic equipmentNot applicable (does not develop therapeutics directly)
Industry: Drug Discovery Services

Partnerships

No major pharma/biotech partnerships publicly listed; collaborates with academic labs and industry customers.

Beyond the preview

Go deeper on MOBILion Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MOBILion Systems.

Explore the full profile